Scilex Holding (SCLX) Retained Earnings (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Retained Earnings of -$965.1 million for Q1 2026, down 315.31% year-over-year from $448.2 million in Q1 2025, and down 16531.05% quarter-over-quarter from -$5.8 million in Q4 2025.
Scilex Holding (SCLX) Retained Earnings (2020 - 2026) Analysis & Trends
Scilex Holding's Retained Earnings history runs 7 years deep, the most recent figure standing at -$965.1 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 315.31% year-over-year to -$965.1 million; the TTM figure through Mar 2026 stood at -$965.1 million (down 315.31% YoY), while the FY2025 annual figure was -$5.8 million, down 191.86% from the prior year.
- Retained Earnings for Q1 2026 stood at -$965.1 million, down from -$5.8 million in the prior quarter.
- The five-year high for Retained Earnings was $448.2 million in Q1 2025, with the low at -$965.1 million in Q1 2026.
- The 5-year median for Retained Earnings is -$8.2 million (2022), against an average of -$78.8 million.
- Peak annual rise in Retained Earnings reached 4063.74% in 2023, while the deepest fall reached 3925.05% in 2023.
- Scilex Holding's Retained Earnings stood at $412.1 million in 2022, then tumbled by 213.76% to -$468.8 million in 2023, then soared by 101.35% to $6.3 million in 2024, then sank by 191.86% to -$5.8 million in 2025, then sank by 16531.05% to -$965.1 million in 2026.
- Business Quant data shows SCLX's Retained Earnings at -$965.1 million in Q1 2026, -$5.8 million in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.03 Bn | 632.27 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 469.62 Bn | 463.05 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 375.00 Bn | 367.85 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 303.31 Bn | 295.62 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.68 Bn | 252.78 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 236.34 Bn | 222.35 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 182.09 Bn | 178.91 Bn | 6.22 Bn | 9.53 Bn |
| 8 | Pfizer | 159.43 Bn | 147.73 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Gsk | 106.25 Bn | 102.08 Bn | 8.24 Bn | 15.38 Bn |
| 10 | Scilex Holding | 39.10 Mn | -73.69 Mn | 3.97 Mn | -1.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -965.10 Mn |
| Dec 31, 2025 | -5.80 Mn |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 448.24 Mn |
| Dec 31, 2024 | 6.32 Mn |
| Sep 30, 2024 | -556.59 Mn |
| Jun 30, 2024 | 426.17 Mn |
| Mar 31, 2024 | -514.62 Mn |
| Sep 30, 2023 | -468.85 Mn |
| Jun 30, 2023 | -433.30 Mn |
| Mar 31, 2023 | 417.73 Mn |
| Dec 31, 2022 | 412.14 Mn |
| Sep 30, 2022 | -12.00 Mn |
| Jun 30, 2022 | -10.77 Mn |
| Mar 31, 2022 | -10.54 Mn |
| Dec 31, 2021 | 128.66 Mn |
| Sep 30, 2021 | -9.83 Mn |
| Jun 30, 2021 | 1.09 Mn |
| Mar 31, 2021 | 3.68 Mn |